Similar articles

• A probiotics trial on trial: the problem of timely detection of adverse advents in therapeutic trials.

  Giard RW. Giard RW. J Clin Epidemiol. 2010 Apr;63(4):347-9. doi: 10.1016/j.jclinepi.2008.12.012. Epub 2009 Sep 17. J Clin Epidemiol. 2010. PMID: 19762211 No abstract available.
• Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials.

  Hutton JL. Hutton JL. Br J Haematol. 2009 Jun;146(1):27-30. doi: 10.1111/j.1365-2141.2009.07707.x. Epub 2009 Apr 27. Br J Haematol. 2009. PMID: 19438480 Review.
• The role of intention to treat in analysis of noninferiority studies.

  Wiens BL, Zhao W. Wiens BL, et al. Clin Trials. 2007;4(3):286-91. doi: 10.1177/1740774507079443. Clin Trials. 2007. PMID: 17715258
• Comments on 'On estimating treatment effects under non-compliance in randomized clinical trials: are intent-to-treat or instrumental variables analyses perfect solutions?' by Heejung Bang and Clarence E. Davis, Statistics in Medicine 2007; 26:954-964.

  Lui KJ. Lui KJ. Stat Med. 2009 Feb 1;28(3):531-4. doi: 10.1002/sim.3479. Stat Med. 2009. PMID: 19125394 No abstract available.
• Intention-to-treat analysis: who is in? Who is out?

  Kruse RL, Alper BS, Reust C, Stevermer JJ, Shannon S, Williams RH. Kruse RL, et al. J Fam Pract. 2002 Nov;51(11):969-71. J Fam Pract. 2002. PMID: 12485553 Review.